Axogen Inc vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF — how do they compare? Axogen Inc trades at $38.37 (market cap $2.06B), while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF trades at $17.11. Which is the better fit depends on your goals.
| AXGN | PDBC | |
|---|---|---|
Market Cap | $2.06B | — |
Sector | Technology | — |
52-Week High | $46.19 | $18.91 |
52-Week Low | $11.28 | $12.90 |
Enterprise Value | $1.98B | — |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
PDBC trades at $16.90, up 2.8% today, with a bullish technical signal supported by moving averages and strong momentum indicators. The ETF has delivered significant returns, including 37% since March 2024, outperforming the S&P 500. Recent news highlights its role as a diversified commodity strategy without K-1 tax forms, attracting institutional interest despite variable dividend payouts tied to commodity prices.
The outlook remains positive due to ongoing commodity strength and geopolitical supply risks, but investors face volatility from fluctuating distributions and potential momentum shifts. Key risks include oil price sensitivity and roll costs, while institutional activity shows mixed signals with some reducing positions.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities. Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals.
Read more on PDBC →